Article
Molecular methods used for detection of minimal residual disease following hematopoietic stem cell transplantation in myeloid disorders.
Methods in molecular biology (Clifton, N.J.) - 1 Jan 2014
Elmaagacli Ahmet H
Abstract excerpt
The monitoring of minimal residual disease (MRD) in patients with acute or chronic myeloid disorders is performed routinely after allogeneic or autologous transplantation. The detection of MRD helps to identify patients who are at high risk for leukemic relapse after transplantation. The most commonly used techniques for MRD detection are qualitative and quantitative PCR methods, fluorescence in situ...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.